Cocrystal Pharma Inc (NASDAQ:COCP)

0.498
Delayed Data
As of Jan 27
 -0.0049 / -0.97%
Today’s Change
0.47
Today|||52-Week Range
3.46
-23.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$52.6M

Company Description

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.

Contact Information

Cocrystal Pharma, Inc.
19805 North Creek Parkway
Bothell Washington 98011
P:(786) 459-1831
Investor Relations:

Employees

Shareholders

Other institutional9.52%
Mutual fund holders6.80%
Individual stakeholders15.56%

Top Executives

Sam LeePresident & Co-Chief Executive Officer
James Joseph MartinCo-Chief Executive Officer, CFO & Secretary
Luz PascualVice President-Clinical Development